Short-term protein restriction at advanced age stimulates FGF21 signalling, energy expenditure and browning of white adipose tissue by Dommerholt, Marleen B et al.
 
 
 University of Groningen
Short-term protein restriction at advanced age stimulates FGF21 signalling, energy
expenditure and browning of white adipose tissue
Dommerholt, Marleen B; Blankestijn, Maaike; Vieira-Lara, Marcel A; van Dijk, Theo H;






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Dommerholt, M. B., Blankestijn, M., Vieira-Lara, M. A., van Dijk, T. H., Wolters, H., Koster, M. H., Gerding,
A., van Os, R. P., Bloks, V. W., Bakker, B. M., Kruit, J. K., & Jonker, J. W. (2020). Short-term protein
restriction at advanced age stimulates FGF21 signalling, energy expenditure and browning of white adipose
tissue. The FEBS Journal. https://doi.org/10.1111/febs.15604
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
Short-term protein restriction at advanced age stimulates
FGF21 signalling, energy expenditure and browning of
white adipose tissue
Marleen B. Dommerholt1 , Maaike Blankestijn1 , Marcel A. Vieira-Lara2 , Theo H. van
Dijk3 , Henk Wolters1, Mirjam H. Koster1, Albert Gerding2,3, Ronald P. van Os4 , Vincent W.
Bloks1 , Barbara M. Bakker2 , Janine K. Kruit1 and Johan W. Jonker1
1 Sections of Molecular Metabolism and Nutrition, Department of Pediatrics, University Medical Center Groningen, University of Groningen,
Groningen, the Netherlands
2 Sections of Systems Medicine of Metabolism and Signaling, Department of Pediatrics, University Medical Center Groningen, University
of Groningen, Groningen, the Netherlands
3 Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, the Netherlands
4 Mouse Clinic for Cancer and Aging, Central Animal Facility, University Medical Center Groningen, University of Groningen, Groningen, the
Netherlands
Keywords
browning of white adipose tissue; dietary
protein restriction; energy metabolism;
FGF21 signalling; thermogenesis
Correspondence
J. K. Kruit, Department of Pediatrics,
University Medical Center Groningen,




J. W. Jonker, Department of Pediatrics,
University Medical Center Groningen,




(Received 28 April 2020, revised 17
September 2020, accepted 19 October
2020)
doi:10.1111/febs.15604
Dietary protein restriction has been demonstrated to improve metabolic
health under various conditions. However, the relevance of ageing and age-
related decline in metabolic flexibility on the effects of dietary protein
restriction has not been addressed. Therefore, we investigated the effect of
short-term dietary protein restriction on metabolic health in young and
aged mice. Young adult (3 months old) and aged (18 months old) C57Bl/
6J mice were subjected to a 3-month dietary protein restriction. Outcome
parameters included fibroblast growth factor 21 (FGF21) levels, muscle
strength, glucose tolerance, energy expenditure (EE) and transcriptomics of
brown and white adipose tissue (WAT). Here, we report that a low-protein
diet had beneficial effects in aged mice by reducing some aspects of age-re-
lated metabolic decline. These effects were characterized by increased
plasma levels of FGF21, browning of subcutaneous WAT, increased body
temperature and EE, while no changes were observed in glucose homeosta-
sis and insulin sensitivity. Moreover, the low-protein diet used in this study
was well-tolerated in aged mice indicated by the absence of adverse effects
on body weight, locomotor activity and muscle performance. In conclu-
sion, our study demonstrates that a short-term reduction in dietary protein
intake can impact age-related metabolic health alongside increased FGF21
signalling, without negatively affecting muscle function. These findings
highlight the potential of protein restriction as a strategy to induce EE and
browning of WAT in aged individuals.
Abbreviations
BAT, brown adipose tissue; BCAA, branched-chain amino acid; CR, caloric restriction; DEG, differentially expressed gene; EE, energy
expenditure; FGF21, fibroblast growth factor 21; H&E, haematoxylin and eosin; HP, high protein; LP, low protein; MP, medium protein;
NEFA, nonesterified fatty acid; RER, respiratory exchange ratio; T2D, type 2 diabetes mellitus; UCP1, uncoupling protein 1; WAT, white
adipose tissue.
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Introduction
Ageing and age-associated changes in lifestyle are
known to affect a wide range of metabolic processes.
Ageing itself is one of the main risk factors for the
development of chronic metabolic diseases, including
type 2 diabetes (T2D), cardiovascular disease and can-
cer [1–3]. With the worldwide increase in life expec-
tancy and median lifespan over the last few decades,
understanding the mechanisms by which ageing affects
metabolic processes has become an increasingly impor-
tant research focus [4,5]. Caloric restriction (CR) is
one of the most effective strategies to delay the symp-
toms of ageing and to extend longevity in a wide vari-
ety of animals [6]. CR, however, is difficult to
maintain, and its long-term success has been limited
by the poor adherence to this diet. Recently, changing
macronutrient balance has emerged as a more feasible
alternative for CR [7–10]. Long-term dietary protein
restriction without reducing total caloric intake has
been shown to have similar beneficial effects on meta-
bolic health and extension of longevity in mice as CR
[11]. Within 1 week after the dietary switch, mice were
protected against obesity and resistant to cold stress as
a result of increased energy expenditure (EE) and
increased utilization of free fatty acids and glucose in
brown adipose tissue (BAT) [12–15].
Mechanisms underlying the beneficial metabolic
effects of protein restriction have been associated with
multiple pathways including mTOR and fibroblast
growth factor 21 (FGF21) signalling. FGF21 has
recently emerged as an endocrine signal associated
with metabolic control, as it is increased in response to
fasting, starvation, protein restriction and physical
exercise as well as overfeeding, ageing and metabolic
diseases such as obesity, T2D and nonalcoholic fatty
liver disease [16–19]. FGF21 signalling is associated
with improved metabolic health and longevity as trans-
genic mice overexpressing FGF21 exhibit increased
lifespan and share a number of beneficial phenotypes
with long lived dwarf mice [20]. Currently, clinical tri-
als are approved for FGF21 analogues in T2D
patients to lower body weight, insulin levels and
plasma triglycerols (TG) [21]. In response to a low-
protein (LP) diet, transcription of Fgf21 is rapidly
induced in the liver by both PPARa signalling and the
GCN2/eIF2 pathway, and FGF21 is subsequently
secreted into the circulation [13,22]. Work on (hepatic)
FGF21-deficient mice showed that the LP diet-induced
effects on basal- and cold-induced EE, insulin sensitiv-
ity, glucose metabolism and fatty acid clearance were
FGF21-dependent [12,23–25]. Together, these studies
suggest that protein restriction induced hepatic FGF21
production and activated BAT and white adipose tis-
sue (WAT) to increase thermogenesis, resulting in
increased EE [22,26,27].
Ageing is, however, associated with diminished lipid
handling, defective thermogenesis and impaired
de novo adipogenesis in subcutaneous WAT and BAT,
which together contribute to the development of age-
dependent insulin resistance and dyslipidaemia [28–30].
During ageing, the expansion of subcutaneous WAT is
accompanied by a decrease in thermogenic capacity of
this depot, reflected by decreased expression of the key
thermogenic marker uncoupling protein 1 (Ucp1) [29]
and a reduced ability to maintain constant body tem-
perature in response to cold exposure [30]. Whether a
short-term protein restriction, starting at an advanced
age, has beneficial effects on metabolic health is not
known. Here, we asked whether a short-term dietary
intervention with reduced protein content would be
able to improve metabolic health at an advanced age.
Using aged mice, we examined the effects of an LP
diet on FGF21 levels, insulin sensitivity, EE and ther-
mogenesis. We found a strong increase in plasma
FGF21 levels in response to low dietary protein intake
in aged mice, accompanied by an improvement in
whole-body energy homeostasis and WAT thermogen-
esis. Together, these findings highlight the role of pro-
tein restriction in the amelioration of the age-related
decline of adipose function.
Results
Effect of dietary protein intake on physical health
in young adult and aged mice
To evaluate the effects of dietary protein content on
metabolic health in the context of ageing, young adult
(3 months old) and aged (18 months old) mice were
given an isocaloric diet (in which protein was replaced
by starch, a complex carbohydrate) with either a
reduced protein content (LP, 7%) or an elevated pro-
tein content (HP, 40%) compared to a control diet
with medium-protein content (MP, 20%) (Fig. 1A).
Over the course of 8 weeks, total intake of the LP diet
was higher in both young adult and aged mice (10.0%,
P = 0.11, and 14.4%, P < 0.001, compared with MP)
(Fig. 1B). As a result of increased intake, absolute
protein intake was effectively reduced by 58.7% in
young adult mice and by 57.7% in the aged mice on
an LP diet (Fig. 1C). An HP diet did not affect food
intake significantly, thereby these mice consumed on
average 188% (young adult mice) and 198% (aged
mice) of protein, compared with littermates on an MP
diet. Despite these substantial changes in protein
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intake, in LP-fed animals, plasma levels of all essential
amino acids were maintained or even increased, except
for the branched-chain amino acids (BCAA), which
were reduced (Fig. 1D).
An important consequence of ageing is the increased
risk of sarcopenia, a risk that is elevated due to
reduced protein supply. To prevent the decline of mus-
cle mass, protein supplementation is often given to
Fig. 1. Body weight and other physiological characteristics in young adult and aged mice. (A) Design of the 12-week dietary intervention and
diet composition of the experimental diets. Young adult mice (3 months of age) and aged mice (18 months of age) were normalized on a
run-in diet for 2 weeks to standardize microbial status (young; n = 13, old; n = 19–22). (B) Food intake, averaged of several measurements
in 8 weeks. (C) Protein intake based on individual differences in food intake. (D) Heat map of average amino acid levels in different
experimental groups (young; n = 8, old; n = 12). (E) Changes in body weight, lean mass (F) and fat mass (G) after 8 weeks of the dietary
treatment (young; n = 13, old; n = 19–22). Physical performance measured by rotarod test over four consecutive days (H), with maximal
running time over day 2/3/4 (I) and learning capacity (K). Correlation plot between body weight and maximal running time (J) (young; n = 13,
old; n = 19–22). Correlation plots between body weight and hanging time (L) or grip strength (M), measured after 8 weeks of the
experimental diet (young; n = 13, old; n = 19–22). Results are shown as Tukey’s box plots or as mean  SEM (B,C,H). In all graphs,
LP = red, MP = grey and HP = blue. Statistical significance was determined by 2-way ANOVA, followed by Tukey’s multiple comparisons
tests and indicated as *P < 0.05, **P < 0.01 and ***P < 0.001. In the correlation plot, young adult mice are represented by open symbols,
while aged mice are represented by solid symbols. Data were analysed using a nonparametric Spearman correlation.
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elderly patients [31–33]. To assess whether reduced
protein intake, in our study, negatively affected physi-
cal strength in aged mice, we measured three markers
of physical health and found no negative conse-
quences. First, either LP or HP did not substantially
affect body weight and body composition throughout
the experiment. Aged mice did not lose weight on
either LP or HP diet, whereas young adult mice dis-
played normal weight gain (Fig. 1E). In addition, both
lean and fat mass were not affected by either an LP or
HP diet (Fig. 1F,G, Table 1). Second, muscle perfor-
mance tests showed an age-related decline of muscle
function, but these changes were not associated with
dietary protein content. Physical performance, mea-
sured by the maximal running time on an accelerating
rotarod, was significantly higher in young adult ani-
mals compared with aged animals (Fig. 1H,I), but
these were mainly associated with differences in body
weight (R2 = 0.562, P < 0.001), with no significant
effect of the diet (Fig. 1J). The motor skill learning
capacity was measured over four consecutive days and
did not significantly change as a function of age or
diet (Fig. 1K). Similar results were obtained with the
hanging wire test and the grip strength test, in which
age-related or body weight-dependent effects were
observed, but no effect of dietary protein content
(Table 1, Fig. 1L,M). Third, we found no significant
effect of dietary protein content on muscle mitochon-
drial content as determined by citrate synthase activity
or mitochondrial function measured by maximal
oxidative capacity on different substrates (Table 2).
Together, these findings indicate that overall physical
health was not significantly affected by a reduced diet-
ary protein intake in either young adult or aged mice
and high-protein (HP) intake in aged mice did not pre-
vent an age-related decline in physical strength.
Effects of reduced dietary protein intake on
glucose homeostasis
As previous studies have reported improved glucose
homeostasis as a result of (periodic) short-term low-
protein feeding [10,11,34,35], we examined the effect of
dietary protein intake on glucose homeostasis. Surpris-
ingly, we did not observe major changes in fasting glu-
cose or insulin levels, glucose tolerance or glucose-
stimulated insulin secretion after LP feeding in either
young adult or aged mice (Fig. 2A,B, Table 3). Only a
small improvement in hepatic insulin sensitivity in
young adult mice on an LP diet was observed by tra-
cer-based glucose kinetics (Fig. 2C,D). In line with
this, mitochondrial oxidative capacity of the liver to
oxidize pyruvate in the presence of malate was
improved in young adult mice on an LP diet (Table 2).
Overall, these results show that dietary protein intake
does not have a major effect on glucose homeostasis in
mice with a stable lean mass and body weight.
Effects of dietary protein intake on energy
expenditure and body temperature
Next, we examined the effect of dietary protein con-
tent on whole-body energy metabolism by indirect
calorimetry. The respiratory exchange ratio (RER)
during the dark phase was significantly increased due
to LP feeding in both young adult and aged mice,
indicating a shift in metabolism towards increased glu-
cose utilization (Fig. 3A,B). In contrast to previous
studies [13,22], EE was not significantly increased in
young adult mice after LP feeding (Fig. 3C). However,
an LP diet substantially affected EE in aged mice.
Analysis of the EE data with body weight as covariant
(ANCOVA) demonstrated a significant LP-induced
increase in EE in aged mice during the dark phase
compared with both MP and HP (Fig. 3D). An HP
diet did not affect EE in both young adult and aged
mice. Furthermore, an LP diet did not significantly
affect voluntary activity, suggesting that the increased
EE was due to an enhanced basal metabolic rate
(Fig. 3E). In line with this, we found an age-related
reduction in body temperature (P < 0.001) and a mod-
erate increase by reduced protein intake (P = 0.067
and P = 0.062 for LP compared with HP diet in young
adult and aged mice, respectively) (Fig. 3F). Together,
these results suggest that EE, and to a lesser extent
body temperature, can be ameliorated by reduced diet-
ary protein intake in aged mice.
Effects of low dietary protein intake on
expression and circulating levels of Fgf21
Previously, it has been shown that the beneficial effects
of protein restriction are mediated by increased hepatic
expression and circulating levels of FGF21 [13,22–24].
In our study, we also observed an increase in plasma
FGF21 levels by an LP diet in the aged mice [average
1638 pgmL1 (LP) vs. 904 pgmL1 (MP)], whereas
young adult mice already displayed relatively high
levels on an MP diet [average 1453 pgmL1 (LP) vs.
1610 pgmL1 (MP)] (Fig. 3G). Conversely, an HP
diet reduced FGF21 levels in both young adult and
aged mice as compared to MP-fed littermates.
While FGF21 is primarily produced by the liver, in
response to metabolic challenges such as fasting and
starvation [13], BAT and WAT have also been shown
to produce FGF21 in response to cold exposure
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[36,37]. In the current study, we observed an effect of
reduced protein intake on Fgf21 in both liver and
BAT. Correlation analysis indicates that 83.2% of the
variation in plasma FGF21 can be explained by stimu-
lation of hepatic Fgf21 mRNA expression (Fig. 3H,I).
In contrast, this induction of Fgf21 in BAT did not
correlate with plasma FGF21 levels (Fig. 3J,K). No
changes in Fgf21 expression were observed in subcuta-
neous WAT in response to an LP diet in either young
adult or aged mice (Fig. 3L). In conclusion, reduced
dietary protein intake increases plasma levels of
FGF21 in aged mice and this is primarily caused by
an induction of hepatic Fgf21 expression.
Effects of dietary protein restriction and age on
brown adipose tissue
The increased EE, body temperature and BAT Fgf21
mRNA levels in response to an LP diet pointed
towards changes in BAT activity. To investigate the
effect of an LP diet on gene expression in BAT, we
performed transcriptome analysis. PCA of all differen-
tially expressed genes (DEGs, P < 0.05) indicated that
the age-related effect was more profound than the
diet-induced effect on gene expression (Fig. 4A). Inter-
estingly, an LP diet increased the variation in gene
expression of both young adult and aged mice
(Fig. 3A), resulting in 297 and 64 (35 common) age-
Table 1. Physiological characteristics in young adult and aged mice. Body weight and composition were determined after 8 weeks of the
experimental diets. Physical capacity of young adult and aged mice were measured before and after 8 weeks of the experimental diet using
the grip strength test and hanging wire test. Young adult animals: n = 13 and aged animals: n = 19–22.
Young animals Aged animals
LP MP HP LP MP HP
Body composition
Body weight (g) 31.2  1.18 30.8  0.77 29.7  0.49 41.2  1.18 41.0  1.19 42.4  1.56
Fat mass (g) 5.5  0.9 4.8  0.5 4.5  0.3 11.4  1.1 11.5  1.0 11.9  1.3
(% of BW) 16.9  2.02 15.2  1.30 15.0  1.03 26.8  1.87 27.2  1.57 26.7  2.04
Lean mass (g) 21.5  0.27 21.7  0.28 21.1  0.36 25.3  0.40 25.3  0.38 25.9  0.42
(% of BW) 69.7  1.85 70.8  1.27 71.0  0.91 62.1  1.54 62.3  1.33 62.2  1.79
Grip strength test
Before diet (GF) 147  6.8 148  5.4 142  4.6 123  4.4 124  4.3 123  5.0
After diet (GF) 139  7.4 135  4.5 136  6.9 110  7.9 114  6.5 110  6.3
Hanging wire test
Before diet (s) 43  2.6 41  3.7 39  3.6 15  1.8 16  1.8 18  2.8
After diet (s) 48  16.1 46  7.2 45  8.4 15  2.9 15  1.1 17  2.1
Table 2. Mitochondrial capacity of liver and quadriceps in young adult and aged mice. Citrate synthase activity was measured in tissue
homogenate (liver or quadriceps) as a marker of mitochondrial content, expressed as µmol/(min∙mg protein). Maximal oxygen consumption
stimulated by different oxidizable substrates was expressed in nmol/(min∙mg mitochondrial protein). PM: pyruvate/malate, PMG: pyruvate/
malate/glutamate, P-CoA palmitoyl-CoA/malate/carnitine. Young adult animals: n = 5–6 and aged animals: n = 8–10.
Young animals Aged animals
LP MP HP LP MP HP
Quadriceps
Citrate synthase 0.42  0.03 0.46  0.04 0.47  0.02 0.43  0.02 0.44  0.01 0.46  0.01
PM 132  9.1 168  14.7 163  10.3 146  11.3 165  16.7 166  13.8
PMG 162  9.9 185  17 175  11.5 157  11.4 181  16.8 181  15.5
P-CoA 50  5.9 49  7.8 60  10.3 50  3 59  5 53  5
Liver
Citrate synthase 0.12  0.04 0.09  0.01 0.11  0 0.09  0.01 0.13  0.01 0.12  0.01
PM 16.1  2.4a 9.2  0.9 9.8  0.7c 13.1  1.1 11.6  0.8 9.2  0.8b
PMG 49  3.5 39  6.9 44  5 41  3.1 50  4.5 43  6.8
P-CoA 35  1.8 23  4.5 27  1.4 29  3.2 37  4.3 25  5
aSignificant compared with MP, p <0.01.; bSignificant compared with MP, p < 0.05.; cSignificant LP vs. HP, p <0.01.
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related DEGs [P < 0.05, false discovery rate
(FDR) = 0.1] for, respectively, MP and LP diets, the
majority of which were upregulated (Fig. 4B,C). Genes
affected by age were associated with low-grade inflam-
mation, such as increased levels of the complement
system, rather than downregulation of specific genes
involved in BAT function (Fig. 4D). Reduced dietary
protein intake resulted in 59 and 32 (10 common)
DEGs in, respectively, young adult and aged mice
(Fig. 4E,F). No effect, however, was observed by an
LP diet on the expression of thermogenic genes,
including Ucp1, peroxisome proliferator-activated
receptor gamma coactivator 1-alpha (Ppargc1a) and
PR domain containing 16 (Prdm16) (Fig. 4G,I), indi-
cating that thermogenesis was not affected.
An alternative explanation for the observed increase
in EE and body temperature could be the increased
size of BAT and increased clearance of glucose and
nonesterified fatty acids (NEFA) [23]. While reduced
dietary protein intake slightly increased BAT weight in
both young adult and aged mice (Fig. 4J), we did not
detect any stimulation of proliferation, as indicated by
the levels of Ki67 mRNA (Fig. 4L). In contrast, we
observed minor differences in BAT morphology
(Fig. 4K) associated with increased levels of the lipid
droplet marker Plin (Fig. 4M), suggesting differences
in BAT were most likely due to lipid accumulation.
Interestingly, we found several other batokines next to
Fgf21 increased in response to an LP diet, including
Bmp8b (increased 5.2-fold and 3.1-fold in young adult
and aged mice, respectively), Lcn2 and Gdf15 (> 3-fold
increased expression levels after LP feeding) (Fig. 4N,
O). Other genes encoding batokines, however, such as
Angplt8, Nrg4, Bmp4 and Bmp7, were not affected
Fig. 2. Glucose tolerance and hepatic insulin sensitivity in young adult and aged mice. Glucose tolerance (A) and insulin response (B) after
oral administration of 1.5 gkg1 BW D-glucose (young; n = 13, old; n = 19). (C) Hepatic insulin sensitivity, before (dashed line) and after
(solid line) 10 weeks of the experimental diet. (D) Hepatic insulin sensitivity, delta AUC (young; n = 13, old; n = 19). Results are shown as
Tukey’s box plots (D), as mean (C) or as mean  SEM (A,B). In all graphs, LP = red, MP = grey and HP = blue. Young adult mice are
represented by open symbols, while aged mice are represented by solid symbols. Statistical significance was determined by 2-way ANOVA,
followed by Tukey’s multiple comparisons tests and indicated as *P < 0.05, and ***P < 0.001.
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(Fig. 4P). In conclusion, while we found no clear evi-
dence for the increased thermogenic capacity of BAT
other than increased BAT weight, an LP diet did
increase the expression of selected batokines.
Effects of dietary protein intake and age on
subcutaneous white adipose tissue
In the absence of major effects on BAT, we investi-
gated whether the observed metabolic improvements
could be mediated by changes in scWAT. We hypothe-
sized that increased EE could be the result of brown-
ing of scWAT, mediated by FGF21. When analysing
the transcriptome of scWAT, similar to BAT, the age-
related effects on gene expression were more pro-
nounced than the diet-induced effects (Fig. 5A). Most
age-related changes in gene expression were observed
on an MP diet, while switching diets to either an LP
or HP diet resulted in increased individual variation,
reducing the number of significant DEGs (Fig. 5B).
On an MP diet, most genes found were downregulated
by ageing, resulting in highly enriched KEGG path-
ways related to ribosomal function or innate immune
cell signalling. In contrast, upregulated genes were
involved in ECM-receptor interactions, focal adhesion
and metabolic pathways (Fig. 5C,D).
Diet changed in total 1124 DEGs significantly in
young adult mice, most of which were the result of HP
feeding (Fig. 5E,F). In contrast, most of the 50 DEGs
significantly changed in aged mice were LP-mediated
(Fig. 5E-G). Pathway enrichment analysis highlighted
changes in the thermogenic pathway (KEGG
mmu04714), oxidative phosphorylation, PPARc sig-
nalling and TCA cycle, as a result of LP feeding
(Fig. 5H). Further, increased levels of Ucp1 mRNA
levels, an essential gene in adaptive thermogenesis,
indicated upregulation of the thermogenic capacity of
scWAT. Ucp1 levels were significantly increased in
aged mice by an LP diet compared with both MP and
HP diets (Fig. 5I). Noticeably, young adult mice on
either an LP or MP diet already exhibited high levels
of Ucp1 compared with mice on an HP diet. In line
with these results, transcriptome data show both age-
related and diet-induced changes in the total thermo-
genic gene profile (Fig. 5J). A clear age-induced differ-
ence in the thermogenic gene profile of MP-fed young
adult and aged mice was found. However, when fed
an LP diet, we found a greater resemblance between
young adult and aged mice, in line with a reversal of
the age-related decline in thermogenic capacity. In
contrast, an HP diet increased the individual variation
between young adult mice, and combining these results
with reduced Ucp1 mRNA expression (Fig. 5I,J),
pointed to a low thermogenic potential. Altogether,
these results suggest regulation of the thermogenic
potential by dietary protein intake.
Effects of reduced dietary protein intake on age-
related browning of scWAT
A rapid age-related decline of the thermogenic capac-
ity of scWAT, as early as 4 months of age, has been
previously shown in mice, including a loss of Ucp1
expression and reduced expression of other thermo-
genic markers such as Cidea, Cox7a1 and Cox8b [29].
Similarly, we found an age-related downregulation of
these genes under MP conditions (Fig. 6A). We fur-
ther investigated the browning capacity of the scWAT
and found a strongly increased expression of the beig-
ing-associated gene Elovl3 due to LP feeding, to the
same extent as Ucp1 (Fig. 6B). However, other beig-
ing-related genes, such as Cd137 (Tnfrsf9) and
Tmem26, only showed a trend towards an increase in
young adult LP-fed mice compared with HP-fed mice
(Fig. 6C). In contrast, classical brown adipocyte-asso-
ciated genes such as Prdm16 and Ppargc1a were not
altered in scWAT (Fig. 6D).
To assess whether changes in Ucp1 mRNA levels
were also accompanied by higher UCP1 protein levels,
we determined protein levels by western analysis and
found a positive correlation with Ucp1 mRNA levels
Table 3. Effects of diet and age on the response to an OGTT.
Mice were given oral administration of 1.5 gkg1 body weight D-
glucose after an overnight (10 h) fast. The AUC was calculated for
both glucose and insulin. Young adult animals: n = 13 and aged
animals: n = 19–22.
3 months 6 month 18 months 21 months
Before exp After exp Before exp After exp
Fasting glucose
LP 6.4  0.4 6.7  0.5 6.5  0.4 5.8  0.4
MP 6.0  0.3 6.2  0.5 6.6  0.4 5.9  0.3
HP 6.7  0.5 6.4  0.4 6.2  0.3 6.2  0.3
AUC glucose
LP 1443  49 1403  65 1278  64 1124  57
MP 1381  59 1418  80 1334  48 1139  36
HP 1472  60 1551  87 1318  66 1210  51
Fasting insulin
LP 0.7  0.10 0.7  0.07 1  0.14 1.4  0.15
MP 0.6  0.13 0.7  0.07 1  0.15 1.3  0.14
HP 0.8  0.28 0.6  0.28 0.8  0.09 1.3  0.13
AUC insulin
LP 28.3  3.9 25.4  2.0 50.7  5.2 70.2  6.9
MP 26.9  5.2 23.5  2.2 45.1  5.3 66.0  6.3
HP 22.4  2.3 23.6  4.0 47.6  3.9 67.0  9.8
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Fig. 3. Diet-induced changes in energy homeostasis and body temperature in aged mice. RER of 48 h in young adult and aged animals (A),
average RER of both light and dark phases (B) (young; n = 10, old; n = 17). (C) EE over 48 h in both young adult and aged mice (young;
n = 10, old; n = 17). (D) ANCOVA-corrected EE of both light and dark phases in aged mice (adjusted body weight = 37.88 g). (E) Average
locomotor activity (cmmin1) during both light and dark phases in young adult and aged mice (young; n = 10, old; n = 17). (F) Body
temperature, measured subcutaneously during the light phase (young; n = 10, old; n = 17). (G) Plasma FGF21 levels in plasma (young;
n = 8, old; n = 12). Fgf21 expression levels in liver (H), BAT (J) and scWAT (L) (young; n = 9, old; n = 12). Correlation plot between plasma
FGF21 levels and Fgf21 mRNA levels in liver (I) and BAT (K) (young; n = 7, old; n = 10). Results are shown as Tukey’s box plots or as
mean  SEM (A,C). In all graphs, LP = red, MP = grey and HP = blue. Statistical significance was determined by 2-way ANOVA, followed
by Tukey’s multiple comparisons tests and indicated as *P < 0.05, **P < 0.01 and ***P < 0.001. In the correlation plots, young adult mice
are represented by open symbols, while aged mice are represented by solid symbols. Data were analysed using a nonparametric Spearman
correlation.
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Fig. 4. Activation of BAT secretory peptide profile by reduced protein intake. (A) PCA plot, plotting all genes with a significant difference
(P < 0.05) in either a diet- or ageing-induced comparison (3791 genes) (n = 4–5). (B) Number of significant DEGs (Padj < 0.1) either
upregulated or downregulated in aged mice compared with young adult mice (n = 4–5), with a Venn diagram showing overlap between
different diets (C). (D) KEGG pathway analysis using DEGs (Padj < 0.1) of age-related changes on an MP diet. (E) Number of significant
DEGs (Padj < 0.1) either upregulated or downregulated by an LP diet compared with MP diet (n = 4–5), with a Venn diagram showing
overlap between ages (F). (G) PCA plot, plotting 225 genes involved in KEGG pathway ‘Thermogenesis’ (mmu04714) (n = 4–5). mRNA
expression levels of Ucp1 (H) and Ppargc1a/Prdm16 (I) and Ki67 (L) in BAT (young; n = 9, old; n = 12). (J) BAT weight, as percentage of
total body weight (young; n = 13, old; n = 19–22). (K) Representative pictures of BAT morphology; scale bar represents 100 µm (n = 4).
RNA-seq expression levels of different Plin genes (M), Bmp8b (N) Lcn2 and Gdf15 (O) (n = 4–5). (P) RNAseq batokine expression profile,
log2 fold change (log2FC) differences between LP- and MP-fed animals. Results are shown as Tukey’s box plots or mean  SEM (N, O),
with LP = red, MP = grey and HP = blue. Statistical significance was determined by 2-way ANOVA, followed by Tukey’s multiple
comparisons tests and indicated as *P < 0.05 and **P < 0.01. In PCA plots, aged LP = light blue, aged MP = dark blue, young adult
LP = light green and young adult MP = dark green.
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Fig. 5. Increased thermogenesis in subcutaneous WAT by reduced protein intake. (A) PCA plot, plotting all genes with a significant difference
(Padj < 0.1) in either a diet- or ageing-induced comparison (7447 genes), LP = blue, MP = green and HP = red, and aged mice are shown in light
while young adult animals are represented in dark colours (n = 5). (B) Number of significant DEGs (Padj < 0.1) either upregulated or downregulated in
aged mice compared with young adult mice, with a Venn diagram showing overlap between different diets (C). (D) KEGG pathway analysis using
downregulated DEGs (Padj < 0.1; green) or upregulated DEGs (Padj < 0.1; red) between young adult and aged animals on an MP diet. (E) Significant
DEGs (Padj < 0.1) either upregulated or downregulated by any dietary interaction, with a Venn diagram showing overlap between the specific dietary
comparisons in young adult mice (F) and aged mice (G). (H) Manual pathway analysis, using all genes significant (P < 0.05) in KEGG-defined
pathways, differences between LP-MP in red and LP-HP in white. (I) mRNA expression levels ofUcp1, LP = red, MP = grey and HP = blue (young;
n = 8, old; n = 12). (J) PCA plots, plotting 225 genes involved in KEGG pathway ‘Thermogenesis’, comparing ages at an LP,MP and HP diets, young
adult mice in dark blue and aged mice in light blue (n = 5). Statistical significance was determined by 2-way ANOVA, followed by Tukey’s multiple
comparisons tests and indicated as *P < 0.05 and **P < 0.01.
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Fig. 6. Selective induction of browning of subcutaneous WAT. (A) RNA-seq expression levels of Cidea, Cox7a1 and Cox8b (n = 5). mRNA
expression levels of Elovl3 (B) Cd137/Tmem26 (C) and Pppargc1a/Prdm16 (D) (young; n = 9, old; n = 12). (E) Representative western blots
of UCP1 protein expression in scWAT (n = 6). (F) Correlation plot between mRNA levels and protein levels of UCP1 (n = 5–6). (G)
Representative pictures of UCP1 staining showing patches of UCP1-rich cells in young adult and aged mice on a LP diet; scale bar
represents 200 µm, with quantification of the number of animals expressing certain patches (young; n = 13, old; n = 19–22) (H). (I) scWAT
weight, as percentage of total body weight (young; n = 13, old; n = 19–22). Average adipocyte size (J) and distribution (K) of both young
adult and aged mice quantifying size of > 100 adipocytes/mouse (young; n = 10, old; n = 13). (L) Plasma NEFA of terminal blood sample,
fasted for 2–6 h (young; n = 8, old; n = 15). (M) Plasma TG of terminal blood sample, fasted for 2–6 h (young; n = 13, old; n = 20). (N)
Correlation plots between Ucp1 mRNA levels and plasma FGF21, EE and body temperature (young; n = 6–8, old; n = 9–11). Results are
shown as mean (H), mean  SEM (A,K) or Tukey’s box plots. In all graphs, LP = red, MP = grey and HP = blue. Statistical significance was
determined by 2-way ANOVA, followed by Tukey’s multiple comparisons tests and indicated as *P < 0.05, **P < 0.01 and ***P < 0.001. In
the correlation plots, young adult mice are represented by open symbols, while aged mice are represented by solid symbols. Data were
analysed using a nonparametric Spearman correlation.
11The FEBS Journal (2020) ª 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
M. B. Dommerholt et al. Metabolic impact of protein restriction at old age
(R2 = 58,2%, P < 0.0001, Fig. 6E,F). Closer examina-
tion of the adipose tissue by UCP1 staining revealed
heterogeneity of scWAT, with sporadic patches of
brown-like adipocytes across the WAT. In animals on
an LP diet, different locations in the tissue contained a
high number of cells with multiple lipid droplets and
high expression of UCP1 protein (representative pic-
ture in Fig. 6G). The UCP1-rich patches were more
frequently present in young adult animals compared
with the aged animals (Fig. 6H). However, an LP diet
was able to increase the number of these patches in
aged mice to levels similar to that of young adult
mice.
In contrast to these patches of UCP1-rich cells, the
surrounding nonthermogenic adipocytes did not
change in morphology. Increased thermogenesis could
potentially affect overall lipid oxidation, adipocyte size
and production of healthy adipokines. However, we
found no differences in scWAT mass, adipocyte size or
distribution upon analysis of representative pictures of
nonthermogenic zones (Fig. 6I–K). In addition, path-
way analysis revealed that other functions such as adi-
pokine signalling and lipolysis were not significantly
altered in the total scWAT depot (Fig. 5H). In line
with this, plasma NEFAs and TG were also not signif-
icantly affected by protein restriction (Fig. 6L,M).
Taken together, while the thermogenic capacity of
scWAT shows an age-related decline, this effect could
be largely reversed by an LP diet. Spearman’s correla-
tions connect Ucp1 mRNA levels to plasma FGF21
levels, EE and body temperature, suggesting that the
reversal of the age-related decline in metabolic health
starts with activating the thermogenic capacity in
scWAT (plasma FGF21 levels; R2 = 22.6%,
P = 0.0006, EE; R2 = 9.7%, P = 0.042, body tempera-
ture; R2 = 16.2%, P = 0.002) (Fig. 6N). Overall, these
data suggest a localized browning in the scWAT,
affecting age-related changes in EE and body tempera-
ture.
Discussion
In Western societies, the percentage of people over the
age of 65 is rapidly increasing. With age, also the risk
of obesity increases, and approximately one-third of
the population develops obesity by the age of 60–70
[38]. Ageing and obesity are prominent risk factors for
many metabolic diseases; therefore, understanding how
ageing negatively affects energy metabolism and identi-
fying strategies to reduce age-related decline in meta-
bolic health are imperative. Dietary protein restriction
has been shown to improve metabolic health in multi-
ple species, including mice and humans [5,7,10,13].
Long-term dietary protein restriction in mice, starting
directly after weaning, also indicated that longevity
can be increased by reduced protein intake [7–9]. How-
ever, whether a short-term intervention with a low-
protein diet starting at an advanced age also has bene-
ficial effects on metabolic health is not known. Here,
we show that short-term dietary protein restriction in
aged mice, starting at the age of 18 months, amelio-
rated the age-related decline of some aspects of meta-
bolic health, including EE, circulating levels of FGF21
and browning of scWAT without noticeable adverse
effects on physical health. Our findings indicate that
interventions based on protein restriction have the
potential to improve metabolic health when started at
an older age. Previous studies into the impact of a
late-life switch to CR reported either no effect or an
increased survival [39–41]. A recent study using dietary
restriction at late-life in female mice showed no meta-
bolic changes in WAT or BAT, indicating that the
body has a memory of earlier nutrition [39]. While
these differences in outcome could have been influ-
enced by differences in experimental design, such as
starting age, duration of the diet or gender, it also sug-
gests that diet composition is an important factor for
the effectiveness of late-life dietary intervention strate-
gies.
Previously, FGF21 has been implicated in increasing
EE and the browning of WAT via brain-mediated
bKlotho signalling [26,27]. Similarly, we found that
plasma FGF21 levels correlated with markers of
browning of scWAT in our study. Both Ucp1 and
Elovl3 mRNA levels in the scWAT were strongly
increased by an LP diet. ELOVL3 has been implicated
as a key thermogenic enzyme as Elovl3-deficient mice
are unable to activate their BAT under conditions of
cold exposure due to a decreased capacity to elongate
saturated fatty acyl-CoAs for heat generation [42].
Other beige-related genes, such as Cd137 and Tmem26,
have been implicated as markers of increased thermo-
genesis in WAT, noted by high expression levels in
beige adipocytes compared with brown and white adi-
pocytes and on specific white preadipocytes with great
potential activate adipogenesis with high thermogenic
capacity [43]. However, in this study, we only observed
minor changes in these genes. In addition, classical
brown adipocyte-associated genes, such as Prdm16 and
Ppargc1a, are thought to be involved in the recruit-
ment of brown preadipocytes, thereby activating ther-
mogenesis from Myf5+ precursor cells [44]. In our
study, these genes were not altered in the total scWAT
depot. As we determined mRNA levels in the total
adipose depot, it could still be these genes are upregu-
lated specifically in the Ucp1-rich patches.
12 The FEBS Journal (2020) ª 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
Metabolic impact of protein restriction at old age M. B. Dommerholt et al.
Furthermore, the finding of the specific UCP1-rich
patches raises the question whether browning of these
locations is due to differentiation of white adipocytes
or infiltration of brown adipocytes. Closer examination
of the areas in WAT with high Ucp1 expression is
needed to provide further information on the mecha-
nisms of browning.
In addition to increased thermogenesis of scWAT,
specific activation of BAT by FGF21 has been shown
previously to increase glucose/NEFA uptake, improve
insulin sensitivity and increase Ucp1 expression
[22,23,26]. However, our LP intervention did not affect
overall insulin homeostasis or Ucp1 expression levels
in BAT. Even though we cannot exclude the possibility
of increased glucose/NEFA clearance by BAT, our
results do not indicate that heat production in BAT is
activated. Besides Fgf21 mRNA expression, we did
found increased expression of other adipokines such as
Bmp8b, Lcn2 and Gdf15 in our transcriptomic data,
which can promote the thermogenic potential of BAT
and WAT. Whether BAT-derived FGF21 reaches the
circulation remains controversial [36,45,46]; however,
it could have indirect effects in this study by stimulat-
ing batokine production. BMP8b is part of a large
family of BMPs that are involved in the differentiation
of white and brown adipocytes, with BMP8b con-
tributing to maximal thermogenic capacity by remod-
elling of the neurovascular network [47,48]. Similarly,
LCN2 and GDF15 are involved in inducing thermoge-
nesis, as suggested by knockout studies and cold-expo-
sure experiments [49–51]. However, as the thermogenic
potential measured by Ucp1 expression was not
induced in BAT after LP intervention, the role of these
batokines in the current study needs to be further eval-
uated.
Insulin resistance plays a central role in the develop-
ment of metabolic diseases. Ageing is associated with
insulin resistance due to age-related changes in adipose
tissue function, mass and distribution [52,53]. These
changes are accompanied by diminished lipid handling,
low-grade inflammation, defective thermogenesis and
impaired de novo adipogenesis [28–30]. In our study,
aged mice displayed insulin resistance, increased adi-
posity and decreased thermogenesis. Short-term LP
feeding did not impact glucose tolerance, insulin sensi-
tivity or adiposity at an advanced age, and only mildly
improved hepatic insulin sensitivity in young adult
mice, without differences in body weight. In contrast
to our observations, some studies have reported
improved glucose homeostasis as a result of LP feed-
ing in both (young) mice and humans [10,11,34,35],
but these latter findings were accompanied by
decreased body weight, potentially explaining the
improved insulin sensitivity. Our results, however,
show that EE and thermogenesis can be improved by
LP feeding in aged mice, indicating that these LP-in-
duced effects are independent of insulin sensitivity and
body weight changes. Interestingly, while aged mice
respond well to a 7% low-protein diet regarding EE,
suggesting that EE and insulin sensitivity could be dis-
tinct features of protein restriction in aged mice, the
effects of LP on EE could not be reproduced in young
adult animals. In young mice, food intake is increased
as a result of LP feeding, and animals do not gain
weight, but changes in EE are not detectable. Subtle
changes in EE, nutrient absorption, activity or a com-
bination of these might explain this discrepancy in
energy balance; however, a larger cohort is needed to
provide answers. In addition, a previous study shows a
divergent effect of 5% or 10% protein diets [54], sug-
gesting a threshold of protein intake to improve meta-
bolic parameters. This hypothesis could also explain
why young adult mice on a 7% protein diet did not
display increased EE. The fact that aged mice did
respond to a 7% protein diet suggests that this thresh-
old could be age-specific.
Epidemiological studies suggest that diets high in
protein and low in carbohydrates are associated with
increased mortality [55]. Data from the Third National
Health and Nutrition Examination Survey (NHANES
III), stratified for age indicated that HP diets (> 20%),
were associated with increased mortality and cancer in
respondents under the age of 65 years, and with a five-
fold increase in diabetes mortality across all ages [56].
In respondents over 65, however, HP intake was asso-
ciated with reduced overall mortality. A possible
explanation is that at an advanced age, low-protein
intake might result in a metabolic decline due to
decreased availability of amino acids, protein anabolic
resistance and immobility. In agreement with the effect
of ageing turning the beneficial effects of protein
restriction on mortality into negative effects, feeding 2-
year-old mice a 4% protein diet led to a rapid weight
loss of 10% in 15 days [56]. Although not measured,
this was likely due to loss of muscle mass, an age-re-
lated risk that is elevated with reduced protein supply
[57]. To avoid muscle mass deterioration at an
advanced age, our study was conducted with a less
restricted protein content of 7%. Dietary protein
restriction reduced plasma levels of BCAAs, which are
often associated with metabolic diseases [58,59], but
increased levels of most other amino acids, suggesting
no signs of amino acid deficiencies. In our study, aged
mice displayed no reduction in body weight, lean mass
or fat mass during the 3-month intervention with dif-
ferent protein diets. Physical tests determining muscle
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mass and function revealed only an age-related decline
and no negative effects of the LP diet, indicating that
moderate protein restriction is well-tolerated at an
advanced age in mice. Interestingly, feeding an HP diet
for 3 months at advanced age did not ameliorate the
age-related decline in muscle strength, suggesting a dis-
crepancy with the common consensus in literature [31–
33]. However, the short duration of the diet and the
age at which the diet is started could have an effect on
the outcome. Starting the diet at 18 months of age,
when the negative effects on grip strength and hanging
wire are still relatively small, the impact of a HP diet
may not have been noticeable, suggesting the conse-
quences of protein intake might be age-specific.
Important to mention is the possible role of carbo-
hydrate intake on the diet-induced effects on energy
metabolism in this study. Firstly, a change in the pro-
tein–carbohydrate ratio changes glucose oxidation,
resulting in increased RER. However, whether these
changes in RER directly affect EE remains unknown.
Secondly, carbohydrate intake could also have influ-
enced hepatic Fgf21 expression by regulation of the
transcription factor ChREBP in conditions of high
sucrose intake [60,61]. In our study, the higher sucrose
content of the AIN-93G semi-synthetic diet compared
with chow might indeed have stimulated hepatic Fgf21
transcription at the start of the experiment. Still, it
does not explain the differences between our experi-
mental groups. In our diet, the protein content has
been substituted with starch, not sucrose. Therefore,
mechanisms underlying Fgf21 stimulation are unlikely
the result of changes in ChREBP regulation by carbo-
hydrate intake. More likely, the amino acid composi-
tion affects FGF21 levels and improves metabolic
health [10,34]. Several diets with reduced levels of
essential amino acids such as methionine or BCAAs
(leucine, isoleucine or valine) mimic the effects of an
LP diet [10,62,63]. Whereas the BCAAs were signifi-
cantly reduced in plasma, most other amino acid levels
were increased by dietary protein restriction in both
ages, which is in line with previous studies [8]. It needs
to be further determined whether mechanisms of hep-
atic Fgf21 transcription are the result of selective
amino acid deprivation.
Conclusion
Taken together, it is evident that an LP diet provides sev-
eral benefits on metabolic health in aged mice. Our study
indicates that an short-term intervention with an optimal
balance of dietary protein and carbohydrates can posi-
tively impact metabolic health in aged individuals as we
find increased EE and thermogenesis, via browning of
WAT, without any negative reduction in muscle function.
We speculate that FGF21-mediated changes in scWAT
are crucial to achieve metabolic health in aged individu-
als, suggesting that age-related decline of adipose func-
tion can be effectively improved by targeting FGF21
signalling. Altogether, this study highlights the possibility
of browning of scWAT to improve metabolic health by
LP feeding in the context of advanced age.
Materials and methods
Animals
Male C57BL/6J mice (The Jackson Laboratory, Bar Har-
bor, ME, USA), bred and aged in our facility, were used at
3 months (n = 13) and 18 months (n = 22) of age in this
study. Animals were housed in a light- and temperature-
controlled facility (12-h light cycle, 21 °C room tempera-
ture) with free access to water and standard chow (RM1;
SDS Diets, Woerden, The Netherlands). Animal experi-
ments were performed with the approval of the National
Ethics Committee for Animal Experiments of The Nether-
lands, in accordance with relevant guidelines and regula-
tions (including laboratory and biosafety regulations). Mice
were excluded from the experiment if they reached humane
endpoint (15% body weight loss or sustained inactivity) or
had developed severe (liver) tumours at the end of the
experiment. In total, < 15% of the aged animals were
excluded from the study, with no substantial differences
between experimental groups.
Animal experiments
To study the short-term metabolic effects of protein intake,
animals were given a semi-synthetic diet, varying in protein
content, for 12 weeks. Prior to the experiment, mice were
given a run-in diet (20% protein control diet) for 2 weeks,
to normalize microbial status. All experimental diets were
based on the AIN-93G breeding diet supplemented with
cysteine (D10012G; Open Source Diets, New Brunswick,
NJ, USA) containing a fixed fat content of 20% (% of
total kcal). Experimental diets consisted of a low-protein
diet (LP; 7% of total kcal), MP diet (control; 20% of total
kcal) and HP diet (40% of total kcal), in which protein is
replaced by an isocaloric amount of starch. For a detailed
description of the diets, see Table S1.
Aged animals (18 months of age) were divided into the
experimental groups, normalized for body weight and 4-h
fasting glucose, insulin and cholesterol levels (Fig. S1).
Young adult animals (3 months of age) were randomly
assigned to one of the three experimental diets. Animals
were weighed weekly and body composition was deter-
mined by nuclear magnetic resonance (NMR), both during
the run-in period and after 8 weeks of the experimental
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diet, using the Bruker Minispec LF110 bicinchoninic acid
Analyzer (Bruker BioSpin, Rheinstetten, Germany). Food
intake was measured several times for a 72-h period. Two
days before termination, mice were injected subcutaneously
with a temperature sensor (IPTT300; BMDS, Seaford DE,
USA), and body temperature was measured the next day
during the light phase. Animals were terminated after a 2-
to 6-h fast, introduced 1 h before the lights were turned on.
A detailed schematic overview of the experimental design is
shown in Fig. 1A.
Muscle strength, endurance and physical
performance tests
The hanging wire test and grip strength test were per-
formed during both the run-in period and after 8 weeks of
the experimental diet to determine changes in physical
strength. Physical health and motor skill learning ability
were tested using the rotarod test after 7 weeks of the
experimental diet.
Grip strength test
Forelimb grip strength was measured using Ametek digital
force gauge (Chatillon DFE II, Elancourt, France). Mice
were positioned to grasp the bar with forelimbs only and
then pulled horizontally until letting go. The test was per-
formed six times (two rounds of three trials each). Within
rounds, mice were given minimal rest (30 s), while between
rounds, mice were returned to their home cage for > 15 min.
The maximum grip strength of the six trials was recorded.
Hanging wire test
Strength and endurance were tested using the hanging wire
test. A wire (3 mm in diameter, 55 cm in length) was sus-
pended between two supports, 35 cm above the tabletop.
Mice were positioned at the centre of the wire, hanging by
their forelimbs. The test was performed six times (two rounds
of three trials each), in which the maximal hanging times
were recorded. Within rounds, mice were given minimal rest
(30 s), while between rounds, mice were returned to their
home cage to rest for > 15 min. Whenever the mouse reached
the end of the wire, it was immediately placed back at the
original position at the centre and recording time continued.
When the mouse turned and fell by its hind limbs, the fall
was considered voluntary and was not counted.
Rotarod test
Neuromuscular performance was determined with the
rotarod apparatus (Series 8; IITC Life Science, Woodland
Hills, CA, USA), using a 4-day protocol. On day 1, mice
were trained to run on a rotating rod, with three runs
accelerating in speed slowly (1–5 r.p.m. in 180 s, 1–5 r.p.m.
in 30 s and 4–10 r.p.m. in 60 s). A fourth run consisted of
the experimental protocol with acceleration from 4 to
20 r.p.m. in 180 s. The running time was measured until
the mice fell or until 300 s was reached. On days 2, 3 and
4, the experimental procedure was repeated three times,
with 15-min rest between runs. For each day, the maximal
running time was recorded. Learning capacity was calcu-
lated as the difference between the maximal running time
on day 3/4 and the experimental run on training day 1.
Indirect calorimetry
Real-time metabolic analyses were performed using a Com-
prehensive Laboratory Animal Monitoring System (TSE
Systems GmbH, Bad Homburg, Germany) at week 11 of
the experimental diet. After a period of overnight acclimati-
zation, carbon dioxide (vCO2) production, oxygen (vO2)
consumption, RER, EE, food intake and activity were
determined for 48 h in individual mice. Infrared beams
recorded locomotor activity according to the number of
beam break events in the horizontal (x) and vertical (z)
planes.
Glucose homeostasis
Glucose homeostasis and insulin sensitivity were deter-
mined at week 10 of the experimental diet, by performing
an oral glucose tolerance test (OGTT) in combination with
analysis of tracer-based glucose kinetics. For this,
1.5 gkg1 body weight D-glucose [25% w/v of which 5%
w/w stable isotope labelled [6,6-2H2]-glucose tracer (Cam-
bridge Isotope Laboratories, Andover, MA, USA)] was
administered orally after an overnight (10 h) fast. At 0, 5,
15, 30, 45, 60, 90 and 120 min after glucose administration,
blood glucose levels were determined using an OneTouch
Select Plus glucose meter (LifeScan, Zug, Switzerland) and
blood spots were collected on filter paper (Sartorius Ste-
dim, TFN 180 gm2, Nieuwegein, The Netherlands) for
tracer analysis [64]. To determine insulin levels, blood spots
were collected at 0, 5, 15, 30, 60 and 120 min after glucose
administration. Insulin was extracted from the blood spots
and determined using the rat insulin ELISA Kit from Crys-
tal Chem and mouse insulin standard (Cat. 90010 and
90020; Zaandam, The Netherlands) according to the manu-
facturers’ protocol. The values for insulin, as measured in
bloodspots, were adjusted by factor 1.28, based on match-
ing samples from plasma. Total area under the curve
(AUC) was calculated for both glucose and insulin curves,
over the periods 0–120 min and 0–30 min, respectively.
Fractional distribution of [6,6-2H2]-glucose was deter-
mined by gas chromatography quadrupole mass spectrome-
try (Agilent 9575C Inert MSD; Agilent Technologies,
Amstelveen, The Netherlands) according to van Dijk et al.
[65]. In short, glucose was extracted from the bloodspot and
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converted to its pentaacetate derivative. Positive chemical
ionization with methane enabled monitoring of ions m/z
408–412 (corresponding to m0–m4 mass isotopologues)
which were corrected for the fractional distribution due to
natural abundance of 13C by multiple linear regression [66]
to obtain the excess fractional distribution (M0–M4) due to
the dilution of administrated [6,6-2H2]-glucose; M2 repre-
sents the fractional contribution of the administered tracer
and was used in the calculations of blood glucose kinetics.
To describe changes in blood glucose kinetics in mice, we
used the minimal model that was adjusted for mice (MiniM)
as developed by van Dijk (Data S1). In short, to generate a
sufficient number of samples that cannot be taken from mice,
we used a mathematical approach using the measured values
at indicated time points. The model used allows estimations
of peripheral glucose utilization rates, peripheral insulin sen-
sitivity and hepatic insulin sensitivities. Hepatic insulin sensi-
tivity was calculated as a ratio of the endogenous glucose
production and the insulin levels over the course of the
experiment, and displayed as the delta AUC (t = 0–
120 min). Relevant equations are shown in the Data S1.
Muscle mitochondrial content and capacity
To determine mitochondrial content and capacity, mito-
chondria were isolated from the quadriceps muscle by dif-
ferential centrifugation as described previously [67]. The O2
fluxes in isolated mitochondria were measured using
MiR05 buffer (respiration buffer) containing 110 mM
sucrose, 60 mM potassium lactobionate, 20 mM taurine,
20 mM HEPES, 0.5 mM EGTA, 10 mM KH2PO4, 3 mM
MgCl2, 1 mgmL1 BSA, pH 7.1 [68] under three condi-
tions, with different oxidizable substrates; (a) 2 mM pyru-
vate plus 2 mM malate; or (b) 2 mM pyruvate plus 2 mM
malate plus 5 mM glutamate; or (c) 25 lM palmitoyl-CoA
plus 2 mM L-carnitine plus 2 mM malate, at 37 °C using a
two-channel high-resolution Oroboros Oxygraph-2k (Oro-
boros, Innsbruck, Austria). The O2 fluxes were normalized
for protein content, determined with the bicinchoninic acid
Protein Assay Kit (Pierce, Thermo Fisher Scientific Inc.,
Rockford, IL, USA) and expressed as nmol/(min∙mg mito-
chondrial protein). Results were corrected for the ratio of
citrate synthase activity (described below) in tissue homoge-
nate to the isolated mitochondria, as a reflection of the
enrichment of mitochondrial preparations.
Citrate synthase activity was determined, as a marker of
mitochondrial content, in isolated mitochondria and
quadriceps homogenates (15%, w/v in PBS) in PBS (pH
7.4), by measuring the formation of 5-thio-2-nitrobenzoic
acid at 412 nm at 37 °C [69]. In short, the assay mixture
contained 0.1 M Tris (pH 8.1), 5 mM triethanolamine/HCl,
0.05 mM EDTA, 0.1% Triton X-100, 0.5 mM oxaloacetate
and 0.1 mM dithionitrobenzoic acid, and the reaction was
started with 0.5 mM acetyl-CoA. Enzyme activities were
expressed as lmol/(min∙mg protein).
Plasma levels of FGF21, free fatty acids,
cholesterol and amino acids
Plasma FGF21 levels were determined using the Mouse/
Rat Quantikine ELISA (MF2100; R&D Systems, Min-
neapolis, MN, USA) according to the manufacturers’ pro-
tocol. Plasma-free fatty acid levels were determined using
the Diasys NEFA FS Kit (#15781; Holzheim, Germany)
according to manufacturers’ protocol, measuring absor-
bance at 540 nm. Plasma cholesterol levels were determined
according to manufacturers’ protocol (Roche, 11489232,
Mannheim, Germany), using Diasys Cholesterol Standard
(#113003010030). Amino acid levels were determined using
cation-exchange high-performance liquid chromatography
followed by postcolumn ninhydrin derivatization, on a Bio-
chrom 30 analyzer (Pharmacia Biotech, Cambridge, UK)
[70]. Norleucine was used as an internal standard. A physi-
ological amino acid calibration standard was used for cali-
bration (Sigma-Aldrich, Darmstadt, Germany).
Adipose tissue histology and
immunohistochemistry
For adipose tissue histology, BAT and subcutaneous white
adipose tissue (scWAT) were fixed in 10% formalin over-
night and paraffin-embedded sections (4 lm) were stained
with haematoxylin and eosin (H&E). Images of scWAT
were taken with Aperio Image Scope (Leica Biosystems,
Amsterdam, The Netherlands) for adipocyte size assess-
ment, in which > 100 adipocytes were randomly counted
for each mouse, using IMAGEJ (NIH, Bethesda, MA, USA).
To assess the thermogenic capacity of adipocytes, H&E
staining of four consecutive slides, interspaced with 300–
400 lm, was scored for the presence of multilocular cells.
To confirm a brown-like phenotype, UCP1 was detected in
paraffin-embedded scWAT tissues by immunohistochem-
istry. The endogenous peroxidase activity was blocked with
1% v/v H2O2 in methanol. After a 15-min treatment with
normal goat serum, sections were incubated overnight at
4 °C with the primary antibody rabbit anti UCP1
(ab10983; Abcam, Cambridge, UK, 1 : 1000 diluted in
PBS). For 30 min, the sections were incubated with the sec-
ondary antibody goat anti-rabbit/biotin (BA-1000; Vector,
1 : 250) and subsequently with VECTASTAIN ABC
Reagents (PK4000; Vector Labs, Burlingame, CA, USA)
for another 30 min. The reaction was visualized by incubat-
ing with 3,30-diaminobenzidine solution for 10 min.
Western analysis
Homogenates of scWAT were prepared using RIPA lysis
buffer (50 mM Tris/HCl, 150 mM NaCl, 5 mM EDTA,
30 mM pyrophosphate, 50 mM NaF, 1% (v/v) Triton X-
100, 1 mM PMSF, 2 mM orthovanadate) with Halt protease
and phosphatase inhibitor cocktail (Thermo Scientific).
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Protein levels were determined, normalized using the bicin-
choninic acid assay (Pierce) and subjected to a 4–15% gra-
dient SDS/PAGE using the Mini Protean 3 System (Bio-
Rad, Hercules, CA, USA), followed by transfer to poly
(vinylidene difluoride) membranes. Standard western analy-
sis was performed using 5% milk in PBS as blocking solu-
tion and antibodies to UCP1 [ab10983, 1.3 µgmL1
(1 : 1000), Abcam] and actin [a2066, 6 µgmL1 (1 : 100),
Sigma, Zwijndrecht, The Netherlands]. HRP-labelled sec-
ondary antibodies were used at 1 : 5000 dilution, and visu-
alization was done by ChemiDoc MP Imaging Systems
(Bio-Rad).
Gene expression analysis
Total RNA was isolated from mouse liver and adipose tis-
sues using phenol/chloroform extraction with TRIzol
(Invitrogen). Transcript levels of synthesized cDNA (M-
MLV reverse transcriptase; Thermo Fisher Scientific, Wal-
tham, MA, USA) were measured with Fast Advance Taq-
Man Master Mix (Applied Biosystems, Foster City, CA,
USA) or Fast Start SYBR Green (Roche) on a QuantStu-
dio 7 Flex Real-time PCR System (Applied Biosystems). Ct
values were normalized by a standard curve and presented
as relative expression of housekeeping gene 36B4. qPCR
primers are listed in Tables S2,S3.
Transcriptome analysis
Total RNA from scWAT and BAT was isolated for RNA
sequencing using the RNeasy MINI Kit (Qiagen, Venlo,
The Netherlands), according to manufacturer’s protocol.
Quality control was performed using a fragment analyser
(ProSize 3.0; Advanced Analytical Technologies, Inc.,
Amstelveen, The Netherlands) confirming all scWAT and
BAT samples had an RNA quality number (RQN) value
greater than 6 and 8, respectively. A total of 1 µg RNA
was used for library preparation and sequencing, performed
at Novogene Co. Ltd. Hong Kong using the Illumina
HiSeq 2500 instrument on the PE150 platform. Paired-end
clean reads were mapped to the reference genome
(mmu_GRCm38.p6) using HISAT2 software. HTSeq was
used to count the read numbers mapped of each gene,
including known and novel genes. Fragments per kilobase
of exon model per million mapped reads of each gene was
calculated based on the length of the gene and reads count
mapped to this gene, as a means of normalizing for the
effect of sequencing depth and gene length.
Differential expression of gene analysis between two
groups (n = 4–5) was performed using DESeq2 R package,
providing statistical routines using a model based on the
negative binomial distribution. The resulting P-values were
adjusted using Benjamini and Hochberg’s approach for
controlling the FDR. Genes with a Padj < 0.1 found by
DESeq2 were assigned as differentially expressed. For vali-
dation of the RNA sequencing data, the expression of sev-
eral genes was also determined by qPCR, and these were
well in agreement with the RNA sequencing outcomes
(Fig. S2).
PCA plots, with 95% confidence levels, were created
using ClustVis (https://biit.cs.ut.ee/clustvis/), and Venn dia-
grams were made using http://www.venndiagrams.net/. For
age-related comparisons, enrichment analysis was per-
formed with DAVID version 6.8 (https://david.ncifc
rf.gov/gene2gene.jsp), using all genes with Padj < 0.1. For
dietary comparisons, enrichment analysis of metabolic
pathways (of KEGG-defined pathways) was performed
manually using all genes with a P < 0.05. Significance of
pathway enrichment was determined by the Fisher exact test,
using GRAPHPAD PRISM 8.3.0 software package (GraphPad
Software, San Diego, CA, USA).
Statistical analysis
GRAPHPAD PRISM 8.3 software package (GraphPad Software)
was used to perform statistical analysis. Data were analysed
by 2-way ANOVA, followed by Tukey’s multiple compar-
isons tests. Correlation graphs were created using a non-
parametric Spearman correlation. EE was correlated with
body weight, and analysis of EE with body weight as
covariate (ANCOVA) was assessed according to the meth-
ods described on www.mmpc.org. Data are presented as
Tukey’s box plots or mean  SEM, as indicated in the fig-
ure legends. Significance is indicated as *P < 0.05,
**P < 0.01 and ***P < 0.001.
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